menu search

SAB Biotherapeutics Presents Virtual 2023 R&D Day Portfolio Update: Breakthrough Immunotherapy Innovations

SAB Biotherapeutics Presents Virtual 2023 R&D Day Portfolio Update: Breakthrough Immunotherapy Innovations
SIOUX FALLS, S.D., May 19, 2023 (GLOBE NEWSWIRE) — SAB Biotherapeutics (NASDAQ: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human immunoglobulins (hIgG), also known as fully-human polyclonal antibodies, without the need for human donors, announced today that it will be hosting its Virtual 2023 Annual R&D Day […] The post SAB Biotherapeutics Presents Virtual 2023 R&D Day Portfolio Update: Breakthrou... Read More
Posted: May 19 2023, 12:30
Author Name: forextv
Views: 102154

Search within

Pages Search Results: